Literature DB >> 4063759

Noninvasive technique using thallium-201 for predicting ischaemic ulcer healing of the foot.

T Ohta.   

Abstract

A post-stress imaging study utilizing single intravenous doses of thallium-201 was performed on feet with trophic skin lesions. Forty-two ischaemic ulcers were classified into four basic types according to the presence and degree of the inherent inflammatory response of the ulcer in both the initial and delayed distributions. Both the relationship between ulcer type and prognosis and the effects of therapy within ulcer type were assessed. The results suggest that ulcers of Type I or Type II heal in response to conservative treatment, while ulcers of Type III, although undergoing healing, require surgical treatment to prevent a protracted hospitalization. In Type IV ulcers, healing is not to be expected at all with conservative therapy; therefore an early decision of amputation may be necessary if surgical measures are not indicated. The technique reported may be helpful not only in the prediction of spontaneous ulcer healing but also in the selection of appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063759     DOI: 10.1002/bjs.1800721115

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Non-invasive investigation of lower limb revascularisation using resting thallium peripheral perfusion imaging.

Authors:  J J Earnshaw; J G Hardy; B R Hopkinson; G S Makin
Journal:  Eur J Nucl Med       Date:  1986

2.  Evaluation of Flap Tissue Viability by F-18 FDG PET/CT.

Authors:  Inki Lee; Seo Young Kang; Chan-Yeong Heo; Ho-Young Lee; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2014-07-01

3.  Quantitative assessment of therapeutic effects in the critically ischemic limb using (99m)Tc-diethylene-triamine-pentaacetic acid human serum albumin.

Authors:  Jun Kawanishi; Takashi Ohta; Hiroyuki Ishibashi; Ikuo Sugimoto; Hirohide Iwata; Masayuki Takahashi; Tetsuya Yamada; Noriyuki Hida
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.